Guntis Karelis

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Randomized phase III study 306

Gregory L. Krauss, José M. Serratosa, Vicente Villanueva et al. · Neurology · 2012 · 429 citations

Medicine, Pharmacology, Pharmacotherapy +15

Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial

Melinda B Roaldsen, Agnethe Eltoft, Tom Wilsgaard et al. · The Lancet Neurology · 2022 · 100 citations · Full text

Medicine, Neurology, Radiology +12

Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis

Jeremy Chataway, Keith F. Martin, Kevin Barrell et al. · Neurology · 2018 · 98 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +15

Clinical Characteristics of Patients with Tick-Borne Encephalitis (TBE): A European Multicentre Study from 2010 to 2017

Benno Kohlmaier, Nina A. Schweintzger, Manfred G. Sagmeister et al. · Microorganisms · 2021 · 83 citations · Full text

Medicine, Infectious Diseases, Neurology +13